{"id":165380,"date":"2024-11-04T07:58:34","date_gmt":"2024-11-04T12:58:34","guid":{"rendered":"https:\/\/44.250.171.167\/?p=165380"},"modified":"2024-11-04T07:58:34","modified_gmt":"2024-11-04T12:58:34","slug":"jubilant-pharmova-ltd-q2fy25-65-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q2fy25-65-rise-in-profits\/","title":{"rendered":"Jubilant Pharmova Ltd Q2FY25; 65% rise in Profits"},"content":{"rendered":"

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.<\/p>\n

\nFinancial Results:<\/h2>\n

Jubilant Pharmova Ltd reported Revenues for Q2FY25 of \u20b91,752.00 Crores up from \u20b91,680.00 Crore year on year, a rise of 4.29%.<\/p>\n

Total Expenses for Q2FY25 of \u20b91,615.00 Crores up from \u20b91,601.00 Crores year on year, a rise of 0.87%.<\/p>\n

Consolidated Net Profit of \u20b9102.00 Crores up 64.52% from \u20b962.00 Crores in the same quarter of the previous year.<\/p>\n

The Earnings per Share is \u20b96.45, up 64.54% from \u20b93.92 in the same quarter of the previous year.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n

*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q2FY25 of \u20b91,752.00 Crores up from \u20b91,680.00 Crore year on year, a rise of 4.29%. Total Expenses for Q2FY25 of \u20b91,615.00 Crores up […]<\/p>\n","protected":false},"author":1863,"featured_media":165381,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[12441,14055,10162],"class_list":["post-165380","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-contract-research","tag-novelty-drugs","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-7.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":168645,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q4fy25-10-rise-in-revenue\/","url_meta":{"origin":165380,"position":0},"title":"Jubilant Pharmova Ltd Q4FY25; 10% rise in Revenue","author":"Chirag Gupta","date":"June 4, 2025","format":false,"excerpt":"Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q4FY25 of \u20b91,929.00 Crores up from \u20b91,759.00 Crore year on year, a rise of 9.66%. Total Expenses for\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166648,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q3fy25-53-rise-in-profits\/","url_meta":{"origin":165380,"position":1},"title":"Jubilant Pharmova Ltd Q3FY25; 53% rise in Profits","author":"Chirag Gupta","date":"February 4, 2025","format":false,"excerpt":"Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q3FY25 of \u20b91,822.00 Crores up from \u20b91,677.00 Crore year on year, a rise of 8.65%. Total Expenses for\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":158356,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q3fy24-8-rise-in-revenue\/","url_meta":{"origin":165380,"position":2},"title":"Jubilant Pharmova Ltd Q3FY24; 8% rise in Revenue","author":"Chirag Gupta","date":"February 2, 2024","format":false,"excerpt":"Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q3FY24 of \u20b91,677.00 Crores up from \u20b91,552.00 Crore year on year, a rise of 8.05%. Total Expenses for\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-24.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-24.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-24.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-24.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-24.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-24.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161673,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q4fy24-5-rise-in-revenue\/","url_meta":{"origin":165380,"position":3},"title":"Jubilant Pharmova Ltd Q4FY24; 5% rise in Revenue","author":"Chirag Gupta","date":"May 29, 2024","format":false,"excerpt":"Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q4FY24 of \u20b91,759.00 Crores up from \u20b91,678.00 Crore year on year, a rise of 4.83%. Total Expenses for\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":155635,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q2fy24-1140-rise-in-profits\/","url_meta":{"origin":165380,"position":4},"title":"Jubilant Pharmova Ltd Q2FY24; 1140% rise in Profits","author":"Hardik Bhandare","date":"November 1, 2023","format":false,"excerpt":"Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q2FY24 of \u20b91,680.00 Crores up from \u20b91,600.00 Crore year on year, a rise of 5.0%. Total Expenses for\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":149401,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q1-fy24-87-fall-in-profits\/","url_meta":{"origin":165380,"position":5},"title":"Jubilant Pharmova Ltd Q1 FY24; 87% fall in Profits","author":"Hardik Bhandare","date":"July 19, 2023","format":false,"excerpt":"Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q1 FY24 of \u20b91,586.90 Crores up from \u20b91,451.70 Crore year on year, a rise of 9.31%. Total Expenses\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-75.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-75.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-75.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-75.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-75.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-75.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/165380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=165380"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/165380\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/165381"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=165380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=165380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=165380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}